Internal Medicine, Hematology & Oncology · Port Jefferson Station, NY
NPI
1285977546
Since 2013
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
3
Hospital affiliations
1500 Route 112 Ste 101
Port Jefferson Station, NY, 11776
Phone (631) 751-3000
Groups this clinician bills Medicare through
Medicare paid, 2024
$3.5M
270,383 services
Medicare patients, 2024
2,602
Average age 75
Drug cost, 2024
$9.9M
2,370 prescriptions
Company payments, 2025
$103K
From 11 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Alfredo E Torres Gonzalez was code J1439 (injection, ferric carboxymaltose, 1 mg), 96,001 times for 113 patients. In total Alfredo E Torres Gonzalez billed 270,383 services in 319 codes, and Medicare paid $3.5M.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2020-04-16.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|
| J1439 Injection, ferric carboxymaltose, 1 mg | Office | 96,001 | 113 | $0.87 | $83K |
| J0881 Injection, darbepoetin alfa, 1 microgram (non-esrd use) | Office | 28,800 | 25 | $2.29 | $66K |
| J0897 Injection, denosumab, 1 mg | Office | 12,660 | 89 | $20.35 | $258K |
| J9271 Injection, pembrolizumab, 1 mg | Office | 12,400 | 25 | $44.61 | $553K |
| J1756 Injection, iron sucrose, 1 mg | Office | 7,600 | 27 | $0.18 | $1,366 |
| 88185 Surgical Pathology Examination | Office | 4,018 | 166 | $22.02 | $88K |
| 85025 Blood Count | Office | 3,889 | 1,604 | $7.56 | $29K |
| 36415 Venipuncture Blood Collection | Office | 3,783 | 1,494 | $8.62 | $33K |
| 80053 Clinical Chemistry | Office | 3,204 | 1,434 | $10.26 | $33K |
| 83735 Clinical Chemistry | Office | 2,735 | 1,136 | $6.50 | $18K |
| 84550 Clinical Chemistry | Office | 2,697 | 1,132 | $4.39 | $12K |
| 83615 Clinical Chemistry | Office | 2,642 | 1,111 | $5.87 | $16K |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 2,400 | 110 | $0.09 | $211 |
| 99214 Office E&M - Established | Office | 2,007 | 871 | $109.31 | $219K |
| 84100 Clinical Chemistry | Office | 1,996 | 1,025 | $4.60 | $9,187 |
By year: 2022 $2.0M for 117,302 services; 2023 $3.1M for 242,233 services; 2024 $3.5M for 270,383 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 88185 Surgical Pathology Examination | 4,018 | 166 | $22.02 | $88K |
| 85025 Blood Count | 3,889 | 1,604 | $7.56 | $29K |
| 36415 Venipuncture Blood Collection | 3,783 | 1,494 | $8.62 | $33K |
| 80053 Clinical Chemistry | 3,204 | 1,434 | $10.26 | $33K |
| 83735 Clinical Chemistry | 2,735 | 1,136 | $6.50 | $18K |
| 84550 Clinical Chemistry | 2,697 | 1,132 | $4.39 | $12K |
| 83615 Clinical Chemistry | 2,642 | 1,111 | $5.87 | $16K |
| 84100 Clinical Chemistry | 1,996 | 1,025 | $4.60 | $9,187 |
| 82728 Clinical Chemistry | 1,982 | 956 | $13.24 | $26K |
| 83540 Clinical Chemistry | 1,958 | 940 | $6.29 | $12K |
Medicare prescription drug claims, 2024
In 2024, the drug Alfredo E Torres Gonzalez prescribed most often to Medicare patients was Aranesp (Darbepoetin Alfa In Polysorbat), with 147 prescriptions and refills. In total Alfredo E Torres Gonzalez wrote 2,370 Medicare prescriptions that cost $9.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Aranesp Darbepoetin Alfa In Polysorbat | 147 | 147 | 30 | $533K |
| Lupron Depot Leuprolide Acetate | 105 | 149 | 17 | $294K |
| Prednisone Generic | 100 | 109 | 24 | $582 |
| Xgeva Denosumab | 99 | 99 | 14 | $313K |
| Eliquis Apixaban | 94 | 150 | 23 | $85K |
| Octagam Immun Globg(Igg)/Malt/Iga Ov50 | 72 | 72 | Under 11 | $546K |
| Darzalex Faspro Daratumumab-Hyaluronidase-Fihj | 66 | 66 | Under 11 | $674K |
| Abiraterone Acetate Generic | 65 | 65 | Under 11 | $51K |
| Revlimid Lenalidomide | 56 | 57 | Under 11 | $1.0M |
| Ibrance Palbociclib | 51 | 51 | Under 11 | $828K |
| Akynzeo Fosnetupitant/Palonosetron | 47 | 47 | 13 | $52K |
| Ondansetron Odt Ondansetron | 44 | 58 | 30 | $1,499 |
| Dexamethasone Generic | 42 | 46 | 22 | $661 |
| Hydroxyurea Generic | 38 | 84 | 11 | $824 |
| Acyclovir Generic | 35 | 63 | Under 11 | $468 |
Brand drugs: 1,224 claims; generic drugs: 1,146 claims; opioid claims: 52.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Alfredo E Torres Gonzalez $103K ($103K in general payments such as food, travel and fees) from 11 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $23K.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 23 | $23K |
| Incyte Corporation INCY | 15 | $15K |
| PharmaEssentia USA Corporation 6446.TW | 14 | $13K |
| Pfizer Inc. PFE | 7 | $12K |
| Aveo Pharmaceuticals, Inc. | 8 | $11K |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 10 | $11K |
| Genzyme Corporation SNY | 6 | $9,755 |
| Regeneron Healthcare Solutions, Inc. REGN | 4 | $5,623 |
| Abbvie Inc. ABBV | 1 | $1,800 |
| Array Biopharma Inc PFE | 1 | $700 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.